Cargando…

Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study

Pseudomonas aeruginosa (Pa) is a major bacterial pathogen responsible for chronic lung infections in cystic fibrosis patients. Recent work has implicated Pf bacteriophages, nonlytic filamentous viruses produced by Pa, in the chronicity and severity of Pa infections. Pf phages act as structural eleme...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourtois, Julie D., Kratochvil, Michael J., Chen, Qingquan, Haddock, Naomi L., Burgener, Elizabeth B., De Leo, Giulio A., Bollyky, Paul L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269214/
https://www.ncbi.nlm.nih.gov/pubmed/34156288
http://dx.doi.org/10.1128/mSystems.00193-21
_version_ 1783720528123527168
author Pourtois, Julie D.
Kratochvil, Michael J.
Chen, Qingquan
Haddock, Naomi L.
Burgener, Elizabeth B.
De Leo, Giulio A.
Bollyky, Paul L.
author_facet Pourtois, Julie D.
Kratochvil, Michael J.
Chen, Qingquan
Haddock, Naomi L.
Burgener, Elizabeth B.
De Leo, Giulio A.
Bollyky, Paul L.
author_sort Pourtois, Julie D.
collection PubMed
description Pseudomonas aeruginosa (Pa) is a major bacterial pathogen responsible for chronic lung infections in cystic fibrosis patients. Recent work has implicated Pf bacteriophages, nonlytic filamentous viruses produced by Pa, in the chronicity and severity of Pa infections. Pf phages act as structural elements in Pa biofilms and sequester aerosolized antibiotics, thereby contributing to antibiotic tolerance. Consistent with a selective advantage in this setting, the prevalence of Pf-positive (Pf+) bacteria increases over time in these patients. However, the production of Pf phages comes at a metabolic cost to bacteria, such that Pf+ strains grow more slowly than Pf-negative (Pf−) strains in vitro. Here, we use a mathematical model to investigate how these competing pressures might influence the relative abundance of Pf+ versus Pf− strains in different settings. Our model suggests that Pf+ strains of Pa cannot outcompete Pf− strains if the benefits of phage production falls onto both Pf+ and Pf− strains for a majority of parameter combinations. Further, phage production leads to a net positive gain in fitness only at antibiotic concentrations slightly above the MIC (i.e., concentrations for which the benefits of antibiotic sequestration outweigh the metabolic cost of phage production) but which are not lethal for Pf+ strains. As a result, our model suggests that frequent administration of intermediate doses of antibiotics with low decay rates and high killing rates favors Pf+ over Pf− strains. These models inform our understanding of the ecology of Pf phages and suggest potential treatment strategies for Pf+ Pa infections. IMPORTANCE Filamentous phages are a frontier in bacterial pathogenesis, but the impact of these phages on bacterial fitness is unclear. In particular, Pf phages produced by Pa promote antibiotic tolerance but are metabolically expensive to produce, suggesting that competing pressures may influence the prevalence of Pf+ versus Pf− strains of Pa in different settings. Our results identify conditions likely to favor Pf+ strains and thus antibiotic tolerance. This study contributes to a better understanding of the unique ecology of filamentous phages in both environmental and clinical settings and may facilitate improved treatment strategies for combating antibiotic tolerance.
format Online
Article
Text
id pubmed-8269214
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-82692142021-08-02 Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study Pourtois, Julie D. Kratochvil, Michael J. Chen, Qingquan Haddock, Naomi L. Burgener, Elizabeth B. De Leo, Giulio A. Bollyky, Paul L. mSystems Research Article Pseudomonas aeruginosa (Pa) is a major bacterial pathogen responsible for chronic lung infections in cystic fibrosis patients. Recent work has implicated Pf bacteriophages, nonlytic filamentous viruses produced by Pa, in the chronicity and severity of Pa infections. Pf phages act as structural elements in Pa biofilms and sequester aerosolized antibiotics, thereby contributing to antibiotic tolerance. Consistent with a selective advantage in this setting, the prevalence of Pf-positive (Pf+) bacteria increases over time in these patients. However, the production of Pf phages comes at a metabolic cost to bacteria, such that Pf+ strains grow more slowly than Pf-negative (Pf−) strains in vitro. Here, we use a mathematical model to investigate how these competing pressures might influence the relative abundance of Pf+ versus Pf− strains in different settings. Our model suggests that Pf+ strains of Pa cannot outcompete Pf− strains if the benefits of phage production falls onto both Pf+ and Pf− strains for a majority of parameter combinations. Further, phage production leads to a net positive gain in fitness only at antibiotic concentrations slightly above the MIC (i.e., concentrations for which the benefits of antibiotic sequestration outweigh the metabolic cost of phage production) but which are not lethal for Pf+ strains. As a result, our model suggests that frequent administration of intermediate doses of antibiotics with low decay rates and high killing rates favors Pf+ over Pf− strains. These models inform our understanding of the ecology of Pf phages and suggest potential treatment strategies for Pf+ Pa infections. IMPORTANCE Filamentous phages are a frontier in bacterial pathogenesis, but the impact of these phages on bacterial fitness is unclear. In particular, Pf phages produced by Pa promote antibiotic tolerance but are metabolically expensive to produce, suggesting that competing pressures may influence the prevalence of Pf+ versus Pf− strains of Pa in different settings. Our results identify conditions likely to favor Pf+ strains and thus antibiotic tolerance. This study contributes to a better understanding of the unique ecology of filamentous phages in both environmental and clinical settings and may facilitate improved treatment strategies for combating antibiotic tolerance. American Society for Microbiology 2021-06-22 /pmc/articles/PMC8269214/ /pubmed/34156288 http://dx.doi.org/10.1128/mSystems.00193-21 Text en Copyright © 2021 Pourtois et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Pourtois, Julie D.
Kratochvil, Michael J.
Chen, Qingquan
Haddock, Naomi L.
Burgener, Elizabeth B.
De Leo, Giulio A.
Bollyky, Paul L.
Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study
title Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study
title_full Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study
title_fullStr Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study
title_full_unstemmed Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study
title_short Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study
title_sort filamentous bacteriophages and the competitive interaction between pseudomonas aeruginosa strains under antibiotic treatment: a modeling study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269214/
https://www.ncbi.nlm.nih.gov/pubmed/34156288
http://dx.doi.org/10.1128/mSystems.00193-21
work_keys_str_mv AT pourtoisjulied filamentousbacteriophagesandthecompetitiveinteractionbetweenpseudomonasaeruginosastrainsunderantibiotictreatmentamodelingstudy
AT kratochvilmichaelj filamentousbacteriophagesandthecompetitiveinteractionbetweenpseudomonasaeruginosastrainsunderantibiotictreatmentamodelingstudy
AT chenqingquan filamentousbacteriophagesandthecompetitiveinteractionbetweenpseudomonasaeruginosastrainsunderantibiotictreatmentamodelingstudy
AT haddocknaomil filamentousbacteriophagesandthecompetitiveinteractionbetweenpseudomonasaeruginosastrainsunderantibiotictreatmentamodelingstudy
AT burgenerelizabethb filamentousbacteriophagesandthecompetitiveinteractionbetweenpseudomonasaeruginosastrainsunderantibiotictreatmentamodelingstudy
AT deleogiulioa filamentousbacteriophagesandthecompetitiveinteractionbetweenpseudomonasaeruginosastrainsunderantibiotictreatmentamodelingstudy
AT bollykypaull filamentousbacteriophagesandthecompetitiveinteractionbetweenpseudomonasaeruginosastrainsunderantibiotictreatmentamodelingstudy